In compliance with current regulations, let us know which audience you belong to:
MGD/DED
Dry Eye Disease (DED) induced by Meibomian Glands Dysfunction (MGD) is a tear film disorder which can be produced by excessive evaporation of tears in 86% of cases.
This evaporation is induced by the obstruction or malfunction of the Meibomian glands that are located in the eyelids and are responsible for producing the tears lipid layer. When these are obstructed, they do not produce enough oily components for the tear film, which consequently evaporates quicker and causes damage to the ocular surface and eye discomfort.
Suggested Protocols
Legend
Single usage
Joint usage
| Application | No. Sittings/Sessions | Frequency | |||||
|---|---|---|---|---|---|---|---|
| DAYS APART, UNLESS SPECIFIED | |||||||
| ApplicationDED da MGD | Technology OPE® IPL | + | LM® LLLT |
Red
Blue
Yellow
|
Recommended Protocol > No. Sittings/Sessions 1x to 3x | > Frequency 5 to 10 | |
| ApplicationMeibomian Glands Dysfunction Dry Eye Disease |
OR
|
||||||
| Technology | LM® LLLT |
Red
Blue
Yellow
|
Recommended Protocol > No. Sittings/Sessions 2x to 4x | > Frequency 2 to 7 | |||
| > Meiboscale™ Degree 1 | 2x of 12min | 2 to 7 | |||||
| > Meiboscale™ Degree 2 | 3x of 14min | 2 to 7 | |||||
| > Meiboscale™ Degree 3 | 3x of 15min w/ GX (Recommended) | 2 to 7 | |||||
| > Meiboscale™ Degree 4 | 4x of 17min w/ GX (Highly Recommended) | 2 to 7 | |||||
| 2x to 4x Recall Sessions | 2x to 4x Recall Sessions | Every 6 to 18 Months | |||||
| ApplicationDED from Other Causes | Technology | LM® LLLT |
Red
Blue
Yellow
|
Recommended Protocol > No. Sittings/Sessions 2x to 4x of 15min | > Frequency 2 to 7 | ||
| Applicatione.g., CLIDE/CLD | Technology |
Red
Blue
Yellow
|
Recommended Protocol > No. Sittings/Sessions | > Frequency | |||
Application
> DED da MGD
Meibomian Glands Dysfunction
Dry Eye Disease
Dry Eye Disease
Application
> DED from Other Causes
e.g., CLIDE/CLD
Scientific Coverage
STONECIPHER, Karl, et al. Combined low level light therapy and intense pulsed light therapy for the treatment of meibomian gland dysfunction. Clinical Ophthalmology (Auckland, NZ), 2019, 13: 993.
GIANNACCARE, Giuseppe, et al. Low-Level Light Therapy Versus Intense Pulsed Light for the Treatment of Meibomian Gland Dysfunction: Preliminary Results From a Prospective Randomized Comparative Study. Cornea, 2022.